Prestige Consumer Healthcare Inc. - 8-K Filing
Prestige Consumer Healthcare reports Q2 fiscal 2027 revenue of $336.3 million and updates full-year guidance due to Clear Eyes® production variability. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $PBH
Read the full article at SEC EDGAR
Part of the story COGNIZANT TECHNOLOGY SOLUTIONS CORP - 8-K Filing (28 articles)